Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Auteurs principaux: Xavier Sáez-Llorens (Auteur), Johnny Beltran-Rodriguez (Auteur), Jose M. Novoa Pizarro (Auteur), Ilhem Mensi (Auteur), Pavitra Keshavan (Auteur), Daniela Toneatto (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...